{"text_format":"3","workbook":"xls","n_sheets":1,"sheets":["India-etc_final enrollemnt number stats"],"not_rendered":{"external_links":1,"defined_names":1},"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"India-etc_final enrollemnt number stats","index":0,"n_rows":22,"n_cols":11,"rows_kept":22,"merged":[[0,0,0,9],[2,2,2,4],[2,5,2,7]],"flags":["formulas_cached_only"]}
["Additional File 16. Planned versus final enrollment from India in the 606 India-etc trials. For the planned enrollment we list the total sample size, sample size from India and fraction from India. For the final enrollment, we list final enrollment numbers achieved (total), final enrollment numbers achieved (India) and fraction from India."]
[]
[null,null,"Planned enrollment",null,null,"Final enrollment"]
["CTRI Number","Phase of Trial","Total sample size","Sample size from India","Fraction from India","Final enrollment numbers achieved (Total)","Final enrollment numbers achieved (India)","Fraction from India","Number of trials","%"]
["CTRI/2016/06/007031","Phase 3",999,100,{"v":0.1001001001001001,"d":"0.1"},1108,107,{"v":0.09657039711191336,"d":"0.1"},1,{"v":0.16501650165016502,"d":"0.2"}]
["CTRI/2016/05/006917","Phase 3",1196,130,{"v":0.10869565217391304,"d":"0.1"},1201,130,{"v":0.10824313072439634,"d":"0.1"},1,{"v":0.16501650165016502,"d":"0.2"}]
["CTRI/2012/08/002859","Phase 3",164,28,{"v":0.17073170731707318,"d":"0.2"},138,13,{"v":0.09420289855072464,"d":"0.1"},1,{"v":0.16501650165016502,"d":"0.2"}]
["CTRI/2011/11/002119","Phase 3",1660,280,{"v":0.1686746987951807,"d":"0.2"},1663,251,{"v":0.15093205051112446,"d":"0.2"},1,{"v":0.16501650165016502,"d":"0.2"}]
["CTRI/2017/03/007979","Phase 4",236,150,{"v":0.635593220338983,"d":"0.6"},184,150,{"v":0.8152173913043478,"d":"0.8"},1,{"v":0.16501650165016502,"d":"0.2"}]
["CTRI/2018/02/011794","Phase 2",420,50,{"v":0.11904761904761904,"d":"0.1"},20,20,{"v":1,"d":"1.0"},1,{"v":0.16501650165016502,"d":"0.2"}]
["CTRI/2015/05/005794","Phase 3",2502,40,{"v":0.01598721023181455,"d":"0.0"},2725,35,{"v":0.012844036697247707,"d":"0.0"},1,{"v":0.16501650165016502,"d":"0.2"}]
["CTRI/2015/12/006412","Phase 3",2600,200,{"v":0.07692307692307693,"d":"0.1"},2782,205,{"v":0.07368799424874191,"d":"0.1"},1,{"v":0.16501650165016502,"d":"0.2"}]
["CTRI/2016/08/007216","Phase 3",416,50,{"v":0.1201923076923077,"d":"0.1"},420,58,{"v":0.1380952380952381,"d":"0.1"},1,{"v":0.16501650165016502,"d":"0.2"}]
["CTRI/2016/05/006967","Phase 4",426,50,{"v":0.11737089201877934,"d":"0.1"},437,45,{"v":0.10297482837528604,"d":"0.1"},1,{"v":0.16501650165016502,"d":"0.2"}]
["CTRI/2017/01/007650","Phase 3",528,80,{"v":0.15151515151515152,"d":"0.2"},553,51,{"v":0.0922242314647378,"d":"0.1"},1,{"v":0.16501650165016502,"d":"0.2"}]
["CTRI/2015/03/005597","Phase 3",7800,200,{"v":0.02564102564102564,"d":"0.0"},7800,302,{"v":0.038717948717948716,"d":"0.0"},1,{"v":0.16501650165016502,"d":"0.2"}]
["CTRI/2014/07/004764","Phase 3",840,100,{"v":0.11904761904761904,"d":"0.1"},859,101,{"v":0.11757857974388825,"d":"0.1"},1,{"v":0.16501650165016502,"d":"0.2"}]
["CTRI/2014/10/005123","Phase 3",858,110,{"v":0.1282051282051282,"d":"0.1"},0,0,0,1,{"v":0.16501650165016502,"d":"0.2"},"For this row, updated information was ‘0’"]
["CTRI/2011/07/001927","Phase 3",1300,35,{"v":0.026923076923076925,"d":"0.0"},0,0,0,1,{"v":0.16501650165016502,"d":"0.2"},"For this row, updated information was ‘0’"]
[{"$nulls":5},"NULL","NULL",null,281,{"v":46.36963696369637,"d":"46.4"}]
[{"$nulls":5},"Applicable only for Completed/Terminated trials","Applicable only for Completed/Terminated trials",null,310,{"v":51.15511551155115,"d":"51.2"}]
[{"$nulls":6},"Total",null,606,100]